Target intelligence / Profile preview

Protozoal cysteine protease

Molecular classification
Enzyme, Protease, Cysteine protease, Peptidase, Clan CA protease, Family C1 cathepsin-like enzyme
01

Overview

Protozoal cysteine proteases are a major class of enzymes employed by parasites to facilitate infection, tissue invasion, immune evasion, protein degradation, autophagy, and cellular egress[1][2]. The most well-characterized families include clan CA cysteine proteases—particularly family C1 cathepsin-like enzymes—which are considered druggable targets in malaria (*Plasmodium* falcipain), Chagas disease (*Trypanosoma cruzi* cruzipain), leishmaniasis, and other protozoan infections. These proteases commonly hydrolyze host or parasite proteins and are involved in key biological processes, including hemoglobin degradation (in *Plasmodium*), cell penetration, and autophagy. Inhibiting these enzymes is a promising approach for chemotherapeutic and vaccine strategies. However, the term "protozoal cysteine-containing proteins" is not standard; the precise therapeutic target class is "protozoal cysteine protease"[1][2].

Other names
Cysteine peptidaseCathepsin-like proteaseClan CA cysteine proteaseCathepsin B-likeCathepsin L-likeFalcipain (in Plasmodium)Cruzipain (in Trypanosoma cruzi)Protease family C1
02

Mechanism of action

Inhibition of proteolytic (protein-degrading) activity by covalent or non-covalent blockade of the catalytic cysteine residue

03

Biological functions

Hydrolysis of proteins (proteolysis)Cell and tissue penetrationModulation/evading host immune responseAutophagyHost cell egressHemoglobin degradation (in Plasmodium)
04

Disease associations

Infection (malaria, leishmaniasis, Chagas disease, toxoplasmosis, cryptosporidiosis, amebiasis)
05

Safety considerations

Off-target effects against host (human) cysteine proteases, leading to potential toxicityPotential for resistance development in parasitesDifficulty achieving selectivity due to conserved active site structure across species
06

Interacting drugs

Cysteine protease inhibitors (many are experimental; notable examples include K11777, E-64, vinyl sulfones, peptidyl inhibitors)

3 more in the full profile.

Beyond the preview

Go deeper on Protozoal cysteine protease.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protozoal cysteine protease.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call